FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/04/018724 [Registered on: 24/04/2019] Trial Registered Prospectively
Last Modified On: 15/04/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A comparison between zinc sulfate and magnesium sulfate gargle before operation to reduce sore throat after operation 
Scientific Title of Study   A prospective, randomized, double blind, placebo controlled study between pre operative magnesium sulfate and zinc sulfate gargle for prevention of post operative sore throat following endotracheal intubation. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Amit Kumar Mondal 
Designation  Post graduate trainee 
Affiliation  Midnapore Medical College 
Address  Department of Anaesthesiology, Midnapore Medical College, Midnapore, Paschim Medinipur

Medinipur
WEST BENGAL
721101
India 
Phone    
Fax    
Email  mitjuhi.mondal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Debasish Bhar 
Designation  Associate Professor 
Affiliation  Midnapore Medical College 
Address  Department of Anaesthesiology, Midnapore Medical College, Midnapore, Paschim Medinipur

Medinipur
WEST BENGAL
721101
India 
Phone    
Fax    
Email  debasish77bhar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Debasish Bhar 
Designation  Associate Professor 
Affiliation  Midnapore Medical College 
Address  Department of Anaesthesiology, Midnapore Medical College, Midnapore, Paschim Medinipur

Medinipur
WEST BENGAL
721101
India 
Phone    
Fax    
Email  debasish77bhar@gmail.com  
 
Source of Monetary or Material Support  
Office of the Principal, Midnapore Medical College, Govt. of West Bengal, Vidyasagar Road, Paschim Medinipur-721101. 
 
Primary Sponsor  
Name  Midnapore Medical College 
Address  Midnapore, Paschim Medinipur, West Bengal. Pin-721101 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Debasish Bhar  Surgery operation theatre  Operation Theatre A, Surgical OT Complex, Department of Surgery, Bidhan Block, Midnapore Medical College, Vidyasagar Road, Midnapore, Paschim Medinipur- 721101
Medinipur
WEST BENGAL 
8697362730

debasish77bhar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Gargle with 5% dextrose solution for 30 seconds 15 min before induction of anaesthesia.   Patients in Group C will receive 20 ml of 5% dextrose solution and will be asked to gargle with this mixture for 30 seconds, 15 min before induction of anesthesia. 
Intervention  Gargle with magnesium sulfate solution and zinc sulfate solution for 30 seconds, 15 min before induction of anesthesia.  Patients in Group A will receive magnesium sulfate solution 20 mg/kg dissolved into 20 ml of 5% dextrose solution and group B will receive zinc sulfate 170 mg dissolved into 20 ml of 5% dextrose solution. Patients will be asked to gargle with this mixture for 30 seconds, 15 min before induction of anesthesia. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients giving valid consent
2.Patients undergoing ASA physical status I & II
3.Patients aged between 18 to 65 years of either sex.
4.Patient undergoing elective laparoscopic cholecystctomy under general anaesthesia.
 
 
ExclusionCriteria 
Details  1.Patient’s refusal.
2.Patients with ASA physical status III or more.
3.Patients posted for emergency surgery
4.Patients with history of alcohol or drug abuse.
5.Patients posted for airway related surgery
6.Pregnancy and lactating mother
7.History of recent sore throat, upper respiratory tract infection, common cold
8.Diabetic patients
9.Long term analgesic therapy
10.Patients with hypersensitivity or contraindication to magnesium or zinc
11.Any history of difficult intubation
12.Difficult intubation requiring more than one attempt
13.Patients with neurological ,psychiatric and neuromuscular disorder
14.Patients requiring introduction of Ryle’s tube in peri-operative period
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of pre operative magnesium sulfate and zinc sulfate gargle on the incidence and severity of post operative sore throat following endotracheal intubation.  July 2019-June 2020 (12 months) 
 
Secondary Outcome  
Outcome  TimePoints 
1) Compare heart rate, mean arterial pressure, respiratory rate and oxygen saturation in post operative period among the study groups.
2) To observe the post operative nausea vomiting, pain, sedation and complications if any
 
July 2019-June 2020 (12 months) 
 
Target Sample Size   Total Sample Size="132"
Sample Size from India="132" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/07/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Background: The antiinflammatory and antinociceptive properties of magnesium by inhibiting calcium entry into the cell and N-methyl-D-aspartate-type (NMDA) glutamate receptors may have a potential role in reducing post operative sore throat (POST).[1] Several studies also demonstrated efficacy of magnesium sulfate to reduce incidence and severity of POST.[2,3]

On the other hand, recent studies with topical zinc has shown that it directly activates receptors that promote epithelial repair and high dose of oral zinc sulfate decreases the intensity of mucositis, xerostomia and pain in individuals undergoing chemotherapy or radiotherapy treatments.[4,5] Recently in 2018, one study has observed significant reduction in the incidence and severity of POST compared to placebo when zinc sulfate lozenges were used preoperatively before endotracheal intubation.[6]

Thus, in the present study we have compared the incidence and severity of post operative sore throat following endotracheal intubation in patient undergoing laparoscopic cholecystectomy after pre operative magnesium sulfate and zinc sulfate gargle.

Methodology: After obtaining permission from Institutional Ethics Committee and written informed consent from patients, 132 adult patients who met inclusion and exclusion criteria will be randomly allocated to three equal groups (n = 44 in each group) using computer generated random number list.

Patients in Group A will receive magnesium sulfate solution 20 mg/kg dissolved into 20 ml of 5% dextrose solution, group B will receive zinc sulfate 170 mg dissolved into 20 ml of 5% dextrose solution , group C will receive 20 ml of 5% dextrose.

Patients will be asked to gurgle slowly with the solution as per allotment of the group and drug for 30 sec, 15 min before induction of anesthesia. The solution for gargle will be wrapped in colored nontransparent glasses to ensure blinding. The anesthesiologist distributing the solution for gargling will be unaware of the constituent of the drug and allotment of the group and similarly resident doctors keeping records of different parameters will also be unaware of the group allotment.

Trachea will be intubated with a soft seal cuffed sterile polyvinyl chloride ETT with a standard cuff and an internal diameter of 7 mm for women and 8 mm for men. Laryngoscopy and tracheal intubation will be performed by an experienced anesthesiologist after ensuring maximum neuromuscular blocking effect as assessed by train‑of‑four (TOF) guard. Tracheal tube cuff will be inflated with sterile water until no air leakage could be heard with a peak airway pressure at 20 cm H2O. Those patients who required more than one attempt for passage of the tube will be excluded from the study.

The patients will be interviewed in a standard fashion by an anesthesiologist (blinded investigator) who is unaware of the group allocation. On arrival in the postanesthesia care unit (0 h), and then at half hourly interval for 2 hours POST will be graded on a four point scale (0–3).[25] After 2 hour POST score will be assessed at 4 hr, 6 hr, 12 hr and 24 hr after extubation. Vital signs, oxygen saturation (SpO2), visual analogue score and sedation score will be recorded at the same time.

Results will be analyzed by unpaired Student’s t-test for parametric data and Mann-Whitney U-test for nonparametric data when two groups will be compared. One-way ANOVA for parametric data and Kruskal-Wallis test for nonparametric data will be used while comparing three groups. Fisher’s exact test and Chi-square test will be used for categorical data as appropriate. P < 0.05 will be considered statistically significant. All statistical tests will be done by "STATISTICA" version 9 (StatSoft, Inc. Tulsa, OK, USA).

Expected outcome: We expect that both of the drugs will reduce the POST following laryngoscopy and endotracheal intubation but which one is superior will only be known after the completion of study.

References:

1) Fawcett WJ, Haxby EJ, Male DA. Magnesium: Physiology and pharmacology. Br J Anaesth 1999; 83:302–20.

2) Borazan H, Kececioglu A, Okesli S, Otelcioglu S. Oral Magnesium Lozenge Reduces Postoperative Sore Throat: A Randomized, Prospective, Placebo-controlled Study.  Anesthesiology 2012;117(3):512-518.

3) Teymourian H, Mohajerani SA, Farahbod A. Magnesium and Ketamine Gargle and Postoperative Sore Throat. Anesth Pain Med. 2015;5(3):e22367.

4) Arbabi-kalati F, Arbabi-kalati F, Deghatipour M, Ansari Moghadam A. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial. Arch Iran Med. 2012 Jul;15(7):413-7.

5) Sharir H, Zinger A, Nevo A, Sekler I, Hershfinkel M. Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J Biol Chem. 2010 Aug 20;285(34):26097-106.

6) Farhang B, Grondin L. The Effect of Zinc Lozenge on Postoperative Sore Throat: A Prospective Randomized, Double-Blinded, Placebo-Controlled Study. Anesth Analg 2018; 126(1):78–83.


 
Close